Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC).
Mark ClemonsSasha MazzarelloJohn HiltonAnil JoyJulie Price-HillerXiaofu ZhuShailendra VermaAnne KehoeMohammed Fk IbrahimMarta SienkiewiczCarol StoberLisa VandermeerBrian HuttonRanjeeta MallickDean FergussonPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2018)
Trial registration: ClinicalTrials.gov : NCT02173262.